Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to 0.45.

  • Ekso Bionics Holdings' Equity Ratio fell 1222.77% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year decrease of 1222.77%. This contributed to the annual value of 0.48 for FY2024, which is 937.15% up from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Equity Ratio stood at 0.45, which was down 1222.77% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Equity Ratio ranged from a high of 0.78 in Q2 2022 and a low of 0.44 during Q4 2023
  • For the 5-year period, Ekso Bionics Holdings' Equity Ratio averaged around 0.59, with its median value being 0.52 (2023).
  • As far as peak fluctuations go, Ekso Bionics Holdings' Equity Ratio skyrocketed by 6051524.55% in 2021, and later crashed by 3308.8% in 2023.
  • Ekso Bionics Holdings' Equity Ratio (Quarter) stood at 0.76 in 2021, then dropped by 17.83% to 0.62 in 2022, then fell by 29.92% to 0.44 in 2023, then rose by 9.37% to 0.48 in 2024, then fell by 6.28% to 0.45 in 2025.
  • Its last three reported values are 0.45 in Q3 2025, 0.47 for Q2 2025, and 0.46 during Q1 2025.